Evidence mapPaperPMID 41329218Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2026

Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications.

Ahmed H Elbanna, Ahmed M El-Dessouki, Sherif S Abdel Mageed, Heba R Ghaiad, Samar S Khalaf, Enas S Gad, Kareem Abdou, Nora M Aborehab, Riham A El-Shiekh, Sherif A Hamdy

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ahmed H ElbannaPharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.
Ahmed M El-DessoukiPharmacology and Toxicology Department, Faculty of Pharmacy6 of October City, Ahram Canadian University, Giza, 12566, Egypt.
Sherif S Abdel MageedPharmacology Department, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Cairo, 11829, Egypt.
Heba R GhaiadBiochemistry Department, Faculty of Pharmacy, Cairo University, Kasr El Ainy St., Cairo, 11562, Egypt. heba.mosalam@pharma.cu.edu.eg.
Samar S KhalafBiochemistry Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
Enas S GadDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
Kareem AbdouCollege of Pharmacy, Al-Ain University, Abu Dhabi, UAE.
Nora M AborehabDepartment of Biochemistry, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.
Riham A El-ShiekhPharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.
Sherif A HamdyPharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For a very long time, herbal treatments have served as remedies for various humans and animals. Natural compounds typically have multiple pharmacological actions because they interact with various biological targets. This characteristic could be exploited to effectively treat disorders with complex physiopathological causes, such as endometriosis. Endometriosis is the proliferation, infiltration, and recurrent bleeding of endometrioid tissue, including stroma and glands, outside the uterine cavity, forming nodules or masses. It affects women of reproductive age and is characterized by persistent inflammation and estrogen dependence, significantly impacting patients' quality of life. Although the precise pathogenic mechanisms remain unclear, current treatments mainly include medication and surgery. Pharmacotherapy typically relies on nonsteroidal anti-inflammatory drugs and hormonal agents, which may cause adverse effects such as gastrointestinal disturbances, hepatic and renal dysfunction, and thrombosis when used as a long-term treatment. Surgical removal of lesions is possible but often followed by recurrence rates of 21.5% after 2 years and up to 50% within 5 years. Therefore, alternative or complementary therapeutic approaches are urgently needed. This review summarizes current evidence on bioactive plant extracts, both crude and refined, and their mechanisms of action against endometriosis, highlighting their multi-target therapeutic potential and underscoring the need for further pre-clinical and clinical studies to develop effective, safer natural treatment strategies.

Indexed as

Biological ProductsEndometriosisPlant ExtractsAnimalsFemaleHumansPhytotherapySignal TransductionBiological ProductsPlant ExtractsAngiogenesisApoptosisEndometriosisNF-κBOxidative stressPI3K/AKT

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.